United Kingdom· GB-APID-35754511000001107
Daxas 250microgram tablets
A roflumilast product containing roflumilast, registered in United Kingdom by AstraZeneca UK Ltd. The same ATC class is registered in 3 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Roflumilast is registered in 3 of 19 countries.
Countries holding a registration under ATC Roflumilast (roflumilast), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Roflumilast · ATC Roflumilast
3 / 19 countries
- Germany
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Roflumilast
- Manufacturer
- AstraZeneca UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- Roflumilast
- ATC class
- Roflumilast
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5000456029148
- gtin05000456054027
- gtin5000456061001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Roflumilast in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDalirespAstraZeneca Pharmaceuticals LP
- SpainDAXAS 250 MICROGRAMOS COMPRIMIDOSAstrazeneca Ab
- NorwayDaxasAstraZeneca
- PolandDaxasAstraZeneca AB
- SwedenDaxas 250 mikrogram TablettAstraZeneca AB
- NetherlandsDaxas 250 microgram tablettenAstraZeneca AB
- FinlandDaxasAstraZeneca AB
- IrelandDaxas 250 micrograms tabletsAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Rofluma, Roflumilast Accord
- Cyprus · Damirast
- Czechia · Rumixafen
- Germany · Roflum Hexal, Roflumila Puren
- Denmark · Firekol
- Spain · Roflumilast Aurovitas
- Finland · Firekol
- Greece · Damirast
- Iceland · Daxas
- Liechtenstein · Daxas
- Norway · Daxas, Firekol
- Portugal · Roflumilaste Generis
- Sweden · Firekol, Roflumilast Accord
- Slovakia · Rumixafen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b4d74674-cbdb-4c5b-965b-04685825dbed GET /v1/drugs/b4d74674-cbdb-4c5b-965b-04685825dbed?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "35754511000001107",
"desc": "Daxas 250microgram tablets (AstraZeneca UK Ltd)",
"form": "Oral tablet",
"vpid": "35813111000001107",
"source": "dmd",
"vtm_id": "777460007",
"strength": "250 microgram",
"substance": "Roflumilast",
"ingredient": "Roflumilast",
"supplier_code": "3583301000001102"
}See everything about roflumilast.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.